1-(3-Chloro-4-fluorophenyl)-3-(4,6-dimethylpyrimidin-2-yl)guanidine

Catalog No.: 
ACZDPW054
CAS No.: 
524057-25-8
Molecular Formula: 
C13H13ClFN5
Molecular Weight: 
293.73
1-(3-Chloro-4-fluorophenyl)-3-(4,6-dimethylpyrimidin-2-yl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%
5g97%
25g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chloro-4-fluorophenyl)-3-(4,6-dimethylpyrimidin-2-yl)guanidine
IUPAC Name1-(3-chloro-4-fluorophenyl)-2-(4,6-dimethylpyrimidin-2-yl)guanidine
Molecular FormulaC13H13ClFN5
Molecular Weight293.73
SMILESN=C(NC1=NC(C)=CC(C)=N1)NC2=CC=C(F)C(Cl)=C2
InChI KeyRGHCLRGUTICRQP-UHFFFAOYSA-N
SynonymN-(3-Chloro-4-fluorophenyl)-N'-(4,6-dimethylpyrimidin-2-yl)guanidine;1-(3-Chloro-4-fluorophenyl)-3-(4,6-dimethylpyrimidin-2-yl)guanidine;Guanidine, N-(3-chloro-4-fluorophenyl)-N'-(4,6-dimethyl-2-pyrimidinyl)-
CAS No.524057-25-8

Synthetic Route by SureRoute

1. ACZDPW054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDPW054 route product structure diagram
    ACZDPW054524057-25-8
Inquiry

2. ACZDPW054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDPW054 route product structure diagram
    ACZDPW054524057-25-8
Inquiry

3. ACZDPW054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDPW054 route product structure diagram
    ACZDPW054524057-25-8
Inquiry

Comments (0)